LNWTC
GSK icon

Laird Norton Wetherby Trust Company’s GSK GSK Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
47,288
+1,955
+4% +$103K 0.05% 290
2026
Q1 		$2.52M Buy
45,333
+2,877
+7% +$156K 0.06% 272
2025
Q4 		$2.1M Buy
+42,456
New +$1.98M 0.04% 311

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Laird Norton Wetherby Trust Company's GSK Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its GSK (GSK) stake by 4.3% in Q2 2026, buying an estimated $103K and bringing the position to 47,288 shares worth $2.5M. The position accounts for 0.05% of the portfolio, ranked #290.

Laird Norton Wetherby Trust Company first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.52M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 47,288 shares of GSK worth $2.5M as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 1,955 GSK shares in Q2 2026, an estimated $103K.
  • GSK made up 0.05% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #290 holding.
  • Laird Norton Wetherby Trust Company first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's GSK position peaked at $2.52M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.